Chromosome 8p engineering reveals increased metastatic potential targetable by patient-specific synthetic lethality in liver cancer.

Huth, Thorben; Dreher, Emely C; Lemke, Steffen; Fritzsche, Sarah; Sugiyanto, Raisatun N; Castven, Darko; Ibberson, David; Sticht, Carsten; Eiteneuer, Eva; Jauch, Anna; Pusch, Stefan; Albrecht, Thomas; Goeppert, Benjamin; Candia, Julián; Wang, Xin Wei; Ji, Junfang; Marquardt, Jens U; Nahnsen, Sven; Schirmacher, Peter and Roessler, Stephanie (2023). Chromosome 8p engineering reveals increased metastatic potential targetable by patient-specific synthetic lethality in liver cancer. Science Advances, 9(51), eadh1442. American Association for the Advancement of Science 10.1126/sciadv.adh1442

[img]
Preview
Text
sciadv.adh1442.pdf - Published Version
Available under License Creative Commons: Attribution (CC-BY).

Download (3MB) | Preview

Large-scale chromosomal aberrations are prevalent in human cancer, but their function remains poorly understood. We established chromosome-engineered hepatocellular carcinoma cell lines using CRISPR-Cas9 genome editing. A 33-mega-base pair region on chromosome 8p (chr8p) was heterozygously deleted, mimicking a frequently observed chromosomal deletion. Using this isogenic model system, we delineated the functional consequences of chr8p loss and its impact on metastatic behavior and patient survival. We found that metastasis-associated genes on chr8p act in concert to induce an aggressive and invasive phenotype characteristic for chr8p-deleted tumors. Genome-wide CRISPR-Cas9 viability screening in isogenic chr8p-deleted cells served as a powerful tool to find previously unidentified synthetic lethal targets and vulnerabilities accompanying patient-specific chromosomal alterations. Using this target identification strategy, we showed that chr8p deletion sensitizes tumor cells to targeting of the reactive oxygen sanitizing enzyme Nudix hydrolase 17. Thus, chromosomal engineering allowed for the identification of novel synthetic lethalities specific to chr8p loss of heterozygosity.

Item Type:

Journal Article (Original Article)

Division/Institute:

04 Faculty of Medicine > Service Sector > Institute of Pathology > Clinical Pathology
04 Faculty of Medicine > Service Sector > Institute of Pathology

UniBE Contributor:

Goeppert, Frank Benjamin

Subjects:

500 Science > 570 Life sciences; biology
600 Technology > 610 Medicine & health

ISSN:

2375-2548

Publisher:

American Association for the Advancement of Science

Language:

English

Submitter:

Pubmed Import

Date Deposited:

27 Dec 2023 12:34

Last Modified:

14 Jan 2024 02:43

Publisher DOI:

10.1126/sciadv.adh1442

PubMed ID:

38134284

BORIS DOI:

10.48350/190723

URI:

https://boris.unibe.ch/id/eprint/190723

Actions (login required)

Edit item Edit item
Provide Feedback